Fool.com: We Buy, Sell, and Praise [Rule Breaker] September 10, 2002: "For big returns to investors, Millennium must produce top-selling drugs and earn more than royalties. It made a smart move to use cash and equity to purchase Leuko-Site and COR Therapeutics, cushioning the downside for investors while it ramps up its research and development machine, but Velcade and others must be approved and succeed in the marketplace. And management must watch stock option grants and other shareholder dilution. "

While my friends at the Fool seem to have rediscovered concepts of equity valuation, they don't really understand the biotech business. Millenium created one of the best target identification organizations in the world. They built up a large cash hoard and have licensing revenue coming in. As far as I can see, they haven't yet built a drug development organization that complements the target side of the business. They've bought some organizations, but the trial progress hasn't yet been evident.   8:48:00 PM    

Time's Shadow: "This is my first production test using Tinderbox to create Time's Shadow. I see I have some work to do to fashion this tool into something that meets my needs and suits my style of writing."

Tinderbox looks like it's gaining advocates for weblogging. As an OS X tool, I'd be restricted to home use.  8:35:56 PM    

My G4 Cube is now upgraded to OS X 10.2. It's a bit snappier perhaps, but other than the new apps, not much different on the surface. OS X is maturing into a stable, fast OS with a Unix core.

I did get suckered by Apple into buying it for one key feature- an IPsec client. The VPN client that's included in the OS is a PPTP only client. Apparently IPsec is built into the OS, but there's no client. Here's hoping that one will be along shortly.  8:26:06 PM